| [1] |
黄哲宙,陈万青,吴春晓,等. 中国女性乳腺癌的发病和死亡现况——全国32 个肿瘤登记点2003-2007 年资料分析报告[J]. 肿瘤,2012,32(6):435-439.
|
| [2] |
Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics[J]. Cancer J Clin,2012,62(4):220-241.
|
| [3] |
张蒲蓉,吕青. 丹参酮的抗肿瘤作用机制及抗乳腺癌的研究现状[J/CD]. 中华乳腺病杂志:电子版,2008,2(4):464-469.
|
| [4] |
Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins[J]. Cancer Lett,2008,269 (2):199-225.
|
| [5] |
Poma P, Notarbartolo M, Labbozzetta M, et al. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis[J]. Int J Mol Med,2007,20(3):329-335.
|
| [6] |
Pati HN, Das U, Das S, et al. The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo [3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones[J]. Eur J Med Chem,2009,44 (1):54-62.
|
| [7] |
Lin L, Hutzen B, Ball S, et al. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells[J]. Cancer Sci,2009,100(9):1719-1727.
|
| [8] |
邬皓,周鹏,李家明,等. 姜黄素衍生物的生物活性研究进展[J].安徽中医学院学报,2012,31(2):77-80.
|
| [9] |
Shishodia S, Chaturvedi MM, Aggarwal BB. Role of curcumin in cancer therapy[J]. Curr Probl Cancer,2007,31(4):243-305.
|
| [10] |
齐晓伟,姜军. 三阴性乳腺癌研究进展[J/CD]. 中华乳腺病杂志:电子版,2008,2(5):612-617.
|
| [11] |
Shehzad A,Wahid F,Lee YS. Curcumin in cancer chemoprevention:molecular targets,pharmacokinetics, bioavailability, and clinical trials[J]. Arch Pharm (Weinheim),2010,343(9):489-499.
|
| [12] |
Labbozzetta M, Notarbartolo M, Poma P, et al. Curcumin as a possible lead compound against hormone-independent, multidrugresistant breast cancer [J]. Ann N Y Acad Sci, 2009,1155:278-283.
|
| [13] |
狄根红,李鹤成,沈镇宙,等. 姜黄素对人乳腺癌细胞增殖的抑制效应及机制[J]. 中华医学杂志, 2003, 83(20):1764-1768.
|
| [14] |
龙丽,曹友德. 姜黄素对乳腺癌MDA-MB-231 细胞NOTCH1和NF-κB 表达的影响[J]. 肿瘤防治研究, 2010,37(2):158-161.
|
| [15] |
王晓飞,郭变琴,张曦文,等. 联氨基姜黄素抑制STAT3 信号通路对乳腺癌MDA-MB-231 细胞侵袭迁移性的影响[J].第三军医大学学报,2011,33(2):111-115.
|
| [16] |
Sun XD, Liu XE, Huang DS. Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression [J]. Mol Med Rep,2012,6(6):1267-1270.
|
| [17] |
Hassan ZK, Daghestani MH. Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line[J]. Asian Pac J Cancer Prev,2012,13(7):3259-3264.
|
| [18] |
Hodges-Gallagher L, Valentine CD, Bader SE, et al.Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells [J]. Breast Cancer Res Treat,2007,105(3):297-309.
|
| [19] |
Yan G, Graham K, Lanza-Jacoby S. Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells[J].Mol Carcinog,2013,52(5):404-411.
|
| [20] |
Lai HW, Chien SY, Kuo SJ, et al. The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin[J/OL]. Evid Based Complement Alternat Med,2012(2012):1-6.[2012-10-20]. http:/ /www. hindawi. com/journals/ecam/2012/486568/cta.
|
| [21] |
Kim S, Park HJ, Bae YH, et al. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion [J].Endocrinology,2012,153(2):554-563.
|
| [22] |
何德,张国君. 肥胖与乳腺癌关系的研究进展[J/CD]. 中华乳腺病杂志:电子版,2012,6 (5):539-544.
|
| [23] |
Zhou QM, Wang XF, Liu XJ, et al. Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo[J]. Acta Pharmacol Sin,2011,32(11):1402-1410.
|
| [24] |
Aggarwal BB, Shishodia S, Takada Y, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice[J]. Clin Cancer Res,2005,11(20):7490-7498.
|
| [25] |
Bachmeier B,Nerlich AG,Iancu CM,et al.The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice[J]. Cell Physiol Biochem,2007,19(1/4):137-152.
|
| [26] |
王辉,牛国梁,张树友,等. 姜黄素对人乳腺癌MDA-MB-231细胞裸鼠移植瘤放射增敏的作用[J]. 中国癌症杂志,2012,22(5):342-346.
|
| [27] |
Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers[J]. Planta Med,1998,64(4):353-356.
|
| [28] |
Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin[J]. Adv Exp Med Biol,2007,595:453-470.
|
| [29] |
Lao CD, Ruffin MT 4th, Normolle D, et al. Dose escalation of a curcuminoid formulation[J]. BMC Complement Altern Med,2006,6:10.
|
| [30] |
Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer[J]. Cancer Biol Ther,2010,9(1):8-14.
|
| [31] |
Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anticancer agent: review of the gap between basic and clinical applications[J]. Curr Med Chem,2010,17(3):190-197.
|
| [32] |
Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells[J]. Nanomedicine,2010,6(1):153-160.
|
| [33] |
Yallapu MM, Othman SF, Curtis ET, et al. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy [J]. Biomaterials,2011,32(7):1890-1905.
|
| [34] |
Mulik RS, Mönkkönen J, Juvonen RO, et al. Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis [J]. Int J Pharm,2010,398(1/2):190-203.
|
| [35] |
Takahashi M, Uechi S, Takara K, et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin[J]. J Agric Food Chem,2009,57(19):9141-9146.
|
| [36] |
Thangapazham RL, Puri A, Tele S, et al. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells[J]. Int J Oncol,2008,32(5):1119-1123.
|
| [37] |
Wang D, Veena MS, Stevenson K, et al. Liposomeencapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappa B by an AKT-independent pathway[J]. Clin Cancer Res,2008,14(19):6228-6236.
|